Life Sciences

Startups have navigated the perilous Valley of Death period with varying levels of success. Conifer Life Sciences Group at MBI is trying to change that.

Loewald’s departure comes after the CFO of the company resigned in May, after it reported a net loss of $12.4 million from fiscal 2024.

Mere weeks after making an unsolicited bid to buy Marlborough-based biotech firm Akoya Biosciences, the anonymous party has withdrawn its offer . 

Two months after its CFO abruptly resigned, Arch Therapeutics, a Framingham-based biotechnology company, has filed for Chapter 11 bankruptcy.

Milford-based Waters Corp. has acquired Halo Labs, a California-based company, which creates specialized imaging technology to detect interfering particles in therapeutic products.

After biotech firm Akoya Biosciences previously announced it would be acquired by Quanterix, the company is now considering an unsolicited, all-cash buyout offer it received from an anonymous third party.

Grant served in various leadership roles at Medtronic from 2004 to 2023.

“Power is the ability to get people to listen to you, even when you're mostly just talking about beer.” - Sam Hendler, Hendler Family Brewing

Story by Jon Weaver, CEO of Massachusetts Biomedical Initiatives

The Power 100 edition is an annual report on how power is shared and expended in Central Massachusetts each year, as told through the 100 people who are most effectively wielding their influence, with a special focus on those creating change and bringing new ideas to the forefront.